The role of matrix metalloproteinases in colorectal cancer
- PMID: 24518611
- PMCID: PMC3980606
- DOI: 10.3390/cancers6010366
The role of matrix metalloproteinases in colorectal cancer
Abstract
In the United States, colorectal cancer (CRC) is the third leading cause of cancer mortality, with limited treatment options for those with advanced disease. Matrix metalloproteinases (MMPs) are important for maintaining extracellular homeostasis but also play a prominent role in cancer cell invasion and dissemination. Expression levels of MMP-1, -2, -7, -9 and -13 correlate with worse outcomes; MMP-12 expression appears to be protective. Hence, MMPs are attractive therapeutic _targets. Previous clinical trials using broad-spectrum MMP inhibitors were disappointing because of off-_target toxicity and lack of efficacy. Now, the availability of safer, more selective inhibitors has renewed interest in therapeutic _targeting of MMPs.
Similar articles
-
Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer.Cancers (Basel). 2021 Dec 10;13(24):6226. doi: 10.3390/cancers13246226. Cancers (Basel). 2021. PMID: 34944846 Free PMC article. Review.
-
Matrix metalloproteinases as biomarkers and therapeutic _targets in colitis-associated cancer.Front Oncol. 2024 Jan 15;13:1325095. doi: 10.3389/fonc.2023.1325095. eCollection 2023. Front Oncol. 2024. PMID: 38288108 Free PMC article. Review.
-
Matrix Metalloproteinases (MMPs) in _targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.Curr Top Med Chem. 2020;20(27):2459-2471. doi: 10.2174/1568026620666200722104928. Curr Top Med Chem. 2020. PMID: 32703131 Review.
-
Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.J Cell Biochem. 2017 Nov;118(11):3531-3548. doi: 10.1002/jcb.26185. Epub 2017 Jul 17. J Cell Biochem. 2017. PMID: 28585723 Free PMC article. Review.
-
Role of matrix metalloproteinases (MMPs) in colorectal cancer.Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):101-17. doi: 10.1023/a:1025867130437. Cancer Metastasis Rev. 2004. PMID: 15000152 Review.
Cited by
-
Predicting Survival Among Colorectal Cancer Patients: Development and Validation of Polygenic Survival Score.Clin Exp Gastroenterol. 2024 Oct 14;17:317-329. doi: 10.2147/CEG.S464324. eCollection 2024. Clin Exp Gastroenterol. 2024. PMID: 39431218 Free PMC article.
-
Cancer Metastases to the Liver: Mechanisms of Tumor Cell Colonization.Pharmaceuticals (Basel). 2024 Sep 23;17(9):1251. doi: 10.3390/ph17091251. Pharmaceuticals (Basel). 2024. PMID: 39338413 Free PMC article. Review.
-
Cancer Prevention and Treatment Based on Lifestyles.Cancer Treat Res. 2024;191:245-279. doi: 10.1007/978-3-031-55622-7_10. Cancer Treat Res. 2024. PMID: 39133411 Review.
-
Comparison of MMP-2, MMP-9, COX-2, and PGP Expression in Feline Injection-Site and Feline Noninjection-Site Sarcomas-Pilot Study.Animals (Basel). 2024 Jul 19;14(14):2110. doi: 10.3390/ani14142110. Animals (Basel). 2024. PMID: 39061572 Free PMC article.
-
Silencing of matrix metalloprotease-12 delays the progression of castration-resistant prostate cancer by regulating autophagy and lipolysis.Braz J Med Biol Res. 2024 Mar 18;57:e13351. doi: 10.1590/1414-431X2024e13351. eCollection 2024. Braz J Med Biol Res. 2024. PMID: 38511770 Free PMC article.
References
-
- Surveillance, Epidemiology, and End Results (SEER) Program. Stat Fact Sheets: Colon and Rectum Cancer. [(accessed on 25 October 2013)]. Available online: http://seer.Cancer.Gov/statfacts/html/colorect.Html/
-
- Howlader N., Noone A., Krapcho M., Neyman N., Aminou R., Waldron W., Altekruse S., Kosary C., Ruhl J., Tatalovich Z., et al. SEER Cancer Statistics Review, 1975–2008. National Cancer Institute; Bethesda, MD, USA: 2011.
-
- Van der Jagt M.F., Wobbes T., Strobbe L.J., Sweep F.C., Span P.N. Metalloproteinases and their regulators in colorectal cancer. J. Surg. Oncol. 2010;101:259–269. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous